TOCILIZUMAB LEVELS ARE ASSOCIATED WITH CLINICAL RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Kneepkens, E. L. [1 ]
Van den Oever, I. A. [1 ]
Plasencia, C. [2 ]
Salcedo Pascual, D. [2 ]
Lopez-Casla, M. T. [2 ]
Van der Kleij, D. [3 ]
Nurmohamed, M. T. [1 ,4 ]
Rispens, T. [5 ]
Balsa, A. [2 ]
Wolbink, G. J. [1 ,5 ]
机构：
[1] Jan van Breemen Res Inst Reade, Amsterdam, Netherlands
[2] La Paz Univ Hosp, Madrid, Spain
[3] Sanquin, Diagnost Serv, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.2915
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0310
引用
收藏
页码：497 / 498
页数：2
相关论文
共 50 条
  • [1] Early Neutropenia Is Associated with Clinical Response in Patients Receiving Tocilizumab in Rheumatoid Arthritis
    Kostine, Marie
    Barnetche, Thomas
    Ardouin, Elodie
    Joly, Marlene
    Rabois, Emilie
    Glace, Baptiste, Sr.
    Nigon, Delphine
    Schaeverbeke, Thierry
    Richez, Christophe
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S558 - S559
  • [2] CLINICAL AND SEROLOGICAL RESPONSE TO TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Casu, C.
    Bruschi, E.
    Alpini, C.
    Marceglia, S.
    Giacomelli, L.
    Epis, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 880 - 880
  • [3] IS EARLY NEUTROPENIA ASSOCIATED WITH CLINICAL RESPONSE IN PATIENTS RECEIVING TOCILIZUMAB IN RHEUMATOID ARTHRITIS?
    Kostine, M.
    Barnetche, T.
    Ardouin, E.
    Joly, M.
    Rabois, E.
    Glace, B.
    Schaeverbeke, T.
    Richez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 377 - 377
  • [4] Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis
    Maldonado-Montoro, Mar
    Canadas-Garre, Marisa
    Gonzalez-Utrilla, Alfonso
    Cristian Plaza-Plaza, Jose
    Angel Calleja-Hernandez, Miguel
    PHARMACOLOGICAL RESEARCH, 2016, 111 : 264 - 271
  • [5] High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis
    Daien, Claire Immediato
    Gailhac, Sarah
    Audo, Rachel
    Mura, Thibault
    Hahne, Michael
    Combe, Bernard
    Morel, Jacques
    RHEUMATOLOGY, 2015, 54 (04) : 601 - 608
  • [6] Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis
    Huang, Hua
    Cen, Han
    Zhou, Li
    Wang, Ting-hui
    Qin, Wen
    Xie, Bin-hua
    Xiao, Dong-Mei
    Wu, Xiu-Di
    Wu, Hua-Xiang
    ARCHIVES OF RHEUMATOLOGY, 2019, 34 (04) : 406 - 413
  • [7] High Levels Of Natural Killer CELLS ARE Associated With Response To Tocilizumab In Patients With Severe Rheumatoid Arthritis.
    Daien, Claire I.
    Gailhac, Sarah
    Audo, Rachel
    Mura, Thibault
    Hahne, Michael
    Combe, Bernard
    Morel, Jacques
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S200 - S201
  • [8] Rheumatoid Factor Level Increased by the Tocilizumab in Rheumatoid Arthritis Patients with Good Clinical Response
    Kaliterna, Dusanka Martinovic
    Radic, Mislav
    Perkovic, Dijana
    Krstulovic, Daniela Marasovic
    Marinovic, Ivanka
    Boric, Katarina
    Aljinovic, Jure
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S39 - S39
  • [9] Associations of genetic polymorphisms with clinical response to tocilizumab in Chinese rheumatoid arthritis patients
    Qin, Wen
    Wang, Meng-Qiao
    Wang, Ting-Hui
    Xiao, Dong-Mei
    Wu, Xiu-Di
    Cen, Han
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 146
  • [10] Rituximab levels are associated with the B cell homeostasis but not with the clinical response in patients with rheumatoid arthritis
    Diaz-Torne, Cesar
    Ortiz, Maria Angels
    Sarmiento, Monica
    Diaz-Lopez, Cesar
    Corominas, Hector
    Casademont, Jordi
    Vidal, Silvia
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2019, 6 (02) : 81 - 84
12345